Search:

Search for text in:

separate each search
term with a space

Multiple terms:

Additional Search Filters:

clear all | select all

Conference Years:

clear all | select all

Days Within Meeting:

clear all | select all

Conferences:

Availability:

clear all | select all

Participation Type:

clear all | select all

Topic Tracks*:

clear all | select all

Organ Site Tracks*:

Showing session: reset

Understanding Mechanism-Based, Cardiovascular Adverse Events Associated with Immune Checkpoint Blockade: Implications for Prevention and Management

  • Sort by:
  • Browse by:
<< first | < prev page: of 1 records per page: next > | last >>
pages: 1 presentations: 1 to 4 of 4
Understanding Mechanism-Based, Cardiovascular Adverse Events Associated with Immune Checkpoint Blockade: Implications for Prevention and Management
Panel Discussion
Laleh Amiri-Kordestani
FDA, Silver Spring, MD, United States
Javid M. Moslehi
Vanderbilt Univ. School of Medicine, Nashville, TN, United States
George D. Demetri
Dana-Farber Cancer Inst. and Harvard Med, Boston, MA, United States
David Feltquate
Bristol-Myers Squibb, New York, NY, United States
Shiv Pillai
Harvard Medical School, Ragon Institute of MGH, MIT and Harvard, Cambridge, MA, United States
Suzanne L. Topalian
Johns Hopkins Kimmel Comp. Cancer Ctr., Baltimore, MD, United States
from AACR Annual Meeting 2017 on April 1, 2017 1:00 PM-2:45 PM
Understanding Mechanism-Based, Cardiovascular Adverse Events Associated with Immune Checkpoint Blockade: Implications for Prevention and Management
Invited Speaker
David Feltquate
Bristol-Myers Squibb, New York, NY, United States
from AACR Annual Meeting 2017 on April 1, 2017 1:00 PM-2:45 PM
Understanding Mechanism-Based, Cardiovascular Adverse Events Associated with Immune Checkpoint Blockade: Implications for Prevention and Management
Invited Speaker
Shiv Pillai
Harvard Medical School, Ragon Institute of MGH, MIT and Harvard, Cambridge, MA, United States
from AACR Annual Meeting 2017 on April 1, 2017 1:00 PM-2:45 PM
Understanding Mechanism-Based, Cardiovascular Adverse Events Associated with Immune Checkpoint Blockade: Implications for Prevention and Management
Invited Speaker
Suzanne L. Topalian
Johns Hopkins Kimmel Comp. Cancer Ctr., Baltimore, MD, United States
from AACR Annual Meeting 2017 on April 1, 2017 1:00 PM-2:45 PM
<< first | < prev page: of 1 records per page: next > | last >>
pages: 1 presentations: 1 to 4 of 4